99 followers
RT @CIR_AACR: #ICYMI: #Lenalidomide skews #macrophages to an M1-like phenotype in #MulipleMyeloma. Learn how the drug triggers #IKZF1 degra…
332 followers
RT @CIR_AACR: #ICYMI: #Lenalidomide skews #macrophages to an M1-like phenotype in #MulipleMyeloma. Learn how the drug triggers #IKZF1 degra…
3,747 followers
#ICYMI: #Lenalidomide skews #macrophages to an M1-like phenotype in #MulipleMyeloma. Learn how the drug triggers #IKZF1 degradation, affecting #IRF5 and #IRF4 expression. @schuetzch https://t.co/CLgtWNtqYP https://t.co/OwyS9ozSBN
57 followers
RT @CIR_AACR: #Lenalidomide skews #macrophages to an M1-like phenotype in #MulipleMyeloma. Learn how the drug triggers #IKZF1 degradation,…
61 followers
RT @CIR_AACR: #Lenalidomide skews #macrophages to an M1-like phenotype in #MulipleMyeloma. Learn how the drug triggers #IKZF1 degradation,…
3,747 followers
#Lenalidomide skews #macrophages to an M1-like phenotype in #MulipleMyeloma. Learn how the drug triggers #IKZF1 degradation, affecting #IRF5 and #IRF4 expression. @schuetzch https://t.co/U39sWHkQXa https://t.co/T7lRYiw2iU
13,749 followers
💊 @UniFAU researchers observed that myeloma-associated #macrophages derived from patients treated with the immunomodulatory drug lenalidomide skewed phenotypically and functionally toward an M1 phenotype. @CIR_AACR 👇 https://t.co/QJukHciYuc https://t.co/